InflaRx is a biopharmaceutical company focused on applying its proprietary anti-C5a and C5aR inhibitors to the treatment of life-threatening or debilitating inflammatory diseases with high unmet medical need. We are committed to innovative science for the discovery and development of transformative treatments for patients.